Prognostic Model Predicting Metastatic Castration-Resistant Prostate Cancer Survival in Men Treated With Second-Line Chemotherapy

BACKGROUND: Several prognostic models for overall survival (OS) have been developed and validated in men with metastatic castration-resistant prostate cancer (mCRPC) who receive first-line chemotherapy. We sought to develop and validate a prognostic model to predict OS in men who had progressed afte...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Halabi, Susan, Lin, Chen-Yen, Small, Eric J., Armstrong, Andrew J., Kaplan, Ellen B., Petrylak, Daniel, Sternberg, Cora N., Shen, Liji, Oudard, Stephane, de Bono, Johann, Sartor, Oliver
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2013
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3833929/
https://ncbi.nlm.nih.gov/pubmed/24136890
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djt280
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak